HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fleet, J. C Search for Related Content PubMed PubMed Citation Articles by Fleet, J. C Agricola Articles by Fleet, J. C

Genomic and proteomic approaches for probing the role of vitamin D in health^1,2,3,4

¹ From the Interdepartmental Nutrition Program and Department of Foods and Nutrition, Purdue University, West Lafayette, IN.

ABSTRACT

Although we have learned a great deal about vitamin D metabolism and function since it first became apparent that this factor was required for bone health, there are still many gaps in our understanding, at both the basic science (eg, the molecular actions and targets of vitamin D) and applied (eg, what "adequate" vitamin D status means) levels. For example, although the identification of extrarenal 1-hydroxylase activity suggests that autocrine/paracrine actions of 1,25-dihydroxyvitamin D complement the classic endocrine actions of the hormone, the practical implications of this finding are only now being explored. In addition, studies showed that 1,25-dihydroxyvitamin D rapidly activates signal transduction pathways in addition to the classic transcriptional activation pathways that require the vitamin D receptor. These new modes of vitamin D action may be crucial to our understanding of both the traditional calcium-regulating actions of vitamin D and the anticancer actions of this essential mediator. Recent developments in genomics and proteomics have provided new opportunities for us to identify molecular targets of vitamin D action. Cancer researchers have demonstrated that these methods have utility for identifying useful biomarkers of disease states. Can these approaches be used to help clarify what constitutes optimal serum concentrations of 25-hydroxyvitamin D? I present an overview of how proteomic and genomic evaluations of cells, animals, and human subjects have been and can be used to improve our understanding of vitamin D biological processes and the role of vitamin D in health.

Key Words: Proteomics • genomics • biomarker

This article has been cited by other articles:

				A. Fausto-Sterling The bare bones of race. Social Studies of Science, October 1, 2008; 38(5): 657 - 694. [Abstract] [PDF]

				E. Seeman and G. J. Strewler Clinical and Basic Research Papers - December 2004 Selections IBMS BoneKEy, January 1, 2005; 2(1): 1 - 5. [Full Text] [PDF]

				D. J Raiten and M. F. Picciano Vitamin D and health in the 21st century: bone and beyond. Executive summary Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1673S - 1677S. [Abstract] [Full Text] [PDF]